User login
- /content/blisibimod-shows-mixed-results-lupus-phase-3-trial
- /edermatologynews/article/153278/lupus-connective-tissue-diseases/blisibimod-shows-mixed-results
- /familypracticenews/article/153278/lupus-connective-tissue-diseases/blisibimod-shows-mixed-results
- /internalmedicinenews/article/153278/lupus-connective-tissue-diseases/blisibimod-shows-mixed-results
- /rheumatologynews/article/153278/lupus-connective-tissue-diseases/blisibimod-shows-mixed-results
- /rheumatology/article/153278/lupus-connective-tissue-diseases/blisibimod-shows-mixed-results-lupus
- /internalmedicine/article/153278/lupus-connective-tissue-diseases/blisibimod-shows-mixed-results
- /dermatology/article/153278/lupus-connective-tissue-diseases/blisibimod-shows-mixed-results-lupus
- /familymedicine/article/153278/lupus-connective-tissue-diseases/blisibimod-shows-mixed-results-lupus